[ET Net News Agency, 8 November 2023] HANSOH PHARMA (03692) rose 3% to HK$15.1.
It hits an intra-day high of HK$15.1, and an intra-day low of HK$14.6. The total shares
traded was 1.59 million, with a value of HK$23.56m. The active buy/sell ratio is 77:23,
with net buying turnover of HK$12.52m. CHINA INNOVATION MARKET SER accounts for greatest
net responsive buying turnover of HK$890,924, with volume weighted average price of
HK$14.865. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive selling turnover
of HK$7.3m, with volume weighted average price of HK$14.857.
The Hang Seng Index now rose 68 points, or 0.4% to 17,738.
Basic Information
=================
---------------------------------
Nominal 15.100 % Chg +3.00%
High 15.100 Low 14.600
Shares Tr 1.59m Turnover 23.56m
10-D SMA 14.490 %H.V 58.693
20-D SMA 13.008 VWAP 14.858
50-D SMA 11.291 RSI14 78.336
---------------------------------
Status: Active buy/sell ratio is 77:23, with net buying turnover of HK$12.52m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 15.10 +3.00
ALI HEALTH (00241) 4.98 +1.84
TRAD CHI MED (00570) 3.66 +1.67
CSPC PHARMA (01093) 7.10 +2.31
SINOPHARM (01099) 19.18 +1.80
SINO BIOPHARM (01177) 3.55 +3.50
CHINARES PHARMA (03320) 4.85 +1.25
SCICLONE PHARMA (06600) 11.10 -1.77
JD HEALTH (06618) 39.65 +3.66
GOLDEN THROAT (06896) 2.79 Unchanged
-----------------------------------------------
(ed)